Home › Funds › Birchview Capital, LP › STOK

Birchview Capital, LP position in STOK

STOKE THERAPEUTICS INC · Health Care

Birchview Capital, LP reported holding 138,000 shares of STOK (STOKE THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$3.6M, representing 2.14% of its reported portfolio and ranking #12 among its reported holdings. Birchview Capital, LP has disclosed STOK holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)138.00K sh
Reported value held$3.59M
Portfolio Weight2.14%
First reportedQ3 2023
Last changeReduce
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How Birchview Capital, LP's STOK position evolved

Birchview Capital, LP first disclosed a stake in STOK in Q3 2023 at 85,000 shares (US$335K). The position peaked in Q4 2025 at 260,000 shares, worth US$8.3M. Across 13 filings, Birchview Capital, LP increased the stake 2 time(s), trimmed it 3 time(s) and left it unchanged 7 time(s). The most recent filing (Q3 2026) shows 138,000 shares valued at US$3.6M — a reduction of -40,110 shares quarter over quarter.. Notable position changes include a 147% increase in Q4 2023 (shares rose 157% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 85.00K $334.90K New
Q4 2023 210.00K $1.10M Add
Q1 2024 210.00K $2.83M Hold
Q2 2024 210.00K $2.84M Hold
Q3 2024 210.00K $2.58M Hold
Q4 2024 210.00K $2.32M Hold
Q1 2025 210.00K $1.40M Hold
Q2 2025 210.00K $2.38M Hold
Q3 2025 210.00K $4.93M Hold
Q4 2025 260.00K $8.25M Add
Q1 2026 210.00K $6.84M Reduce
Q2 2026 178.11K $5.83M Reduce
Q3 2026 138.00K $3.59M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About STOK and 13F data

STOK (STOKE THERAPEUTICS INC) is a Health Care company. 48 other funds we track also report a position in STOK — the largest reported positions include RTW INVESTMENTS, LP (US$184.0M), Lynx1 Capital Management LP (US$132.1M), Redmile Group, LLC (US$129.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding STOK

All STOK fund holders →

FAQ

How long has Birchview Capital, LP held STOK?

Birchview Capital, LP has disclosed STOK holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Birchview Capital, LP's current position in STOK?

As of Q3 2026, Birchview Capital, LP holds 138.00K shares of STOK (STOKE THERAPEUTICS INC), valued at $3.59M, representing 2.14% of its reported portfolio and ranking #12.

Has Birchview Capital, LP been buying or selling STOK?

In the latest 13F filing (Q3 2026), Birchview Capital, LP reduced its position in STOK. The position peaked in Q4 2025 at 260.00K shares.

Which other funds hold STOK?

Other major institutional holders of STOK include RTW INVESTMENTS, LP, Lynx1 Capital Management LP, Redmile Group, LLC, among 48 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.